Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depression.
Johnson DE, Rodrigues NB, Weisz S, Chisamore N, Kaczmarek ES, Chen-Li DCJ, Doyle Z, Richardson JD, Mansur RB, McIntyre RS, Rosenblat JD. Johnson DE, et al. Among authors: doyle z. Eur Neuropsychopharmacol. 2024 Dec 5;91:69-77. doi: 10.1016/j.euroneuro.2024.11.008. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 39642450 Free article.
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.
Danayan K, Chisamore N, Rodrigues NB, Vincenzo JDD, Meshkat S, Doyle Z, Mansur R, Phan L, Fancy F, Chau E, Tabassum A, Kratiuk K, Arekapudi A, Teopiz KM, McIntyre RS, Rosenblat JD. Danayan K, et al. Among authors: doyle z. Psychiatry Res. 2023 May;323:115133. doi: 10.1016/j.psychres.2023.115133. Epub 2023 Mar 5. Psychiatry Res. 2023. PMID: 36889160 Clinical Trial.
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
Chisamore N, Danayan K, Rodrigues NB, Di Vincenzo JD, Meshkat S, Doyle Z, Mansur R, Phan L, Fancy F, Chau E, Tabassum A, Kratiuk K, Arekapudi A, McIntyre RS, Rosenblat JD. Chisamore N, et al. Among authors: doyle z. J Psychopharmacol. 2023 Aug;37(8):775-783. doi: 10.1177/02698811231171531. Epub 2023 May 16. J Psychopharmacol. 2023. PMID: 37194253 Free PMC article.
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
Rosenblat JD, Meshkat S, Doyle Z, Kaczmarek E, Brudner RM, Kratiuk K, Mansur RB, Schulz-Quach C, Sethi R, Abate A, Ali S, Bawks J, Blainey MG, Brietzke E, Cronin V, Danilewitz J, Dhawan S, Di Fonzo A, Di Fonzo M, Drzadzewski P, Dunlop W, Fiszter H, Gomes FA, Grewal S, Leon-Carlyle M, McCallum M, Mofidi N, Offman H, Riva-Cambrin J, Schmidt J, Smolkin M, Quinn JM, Zumrova A, Marlborough M, McIntyre RS. Rosenblat JD, et al. Among authors: doyle z. Med. 2024 Mar 8;5(3):190-200.e5. doi: 10.1016/j.medj.2024.01.005. Epub 2024 Feb 14. Med. 2024. PMID: 38359838 Clinical Trial.
The pathway to more rural doctors: the role of universities.
McGrail MR, Doyle Z, Fuller L, Gupta TS, Shires L, Walters L. McGrail MR, et al. Among authors: doyle z. Med J Aust. 2023 Aug 7;219 Suppl 3:S8-S13. doi: 10.5694/mja2.52021. Med J Aust. 2023. PMID: 37544002 No abstract available.
31 results